Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia.

Autor: Talati C; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL chetasi.talati@gmail.com., Dhulipala VC; Maur y Regional Cancer Center, Columbia, TN., Extermann MT; Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Department of Oncology Sciences, University of South Florida, Tampa, FL., Ali NA; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Kim J; Maur y Regional Cancer Center, Columbia, TN.; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL., Komrokji R; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sweet K; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Kuykendall A; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Maur y Regional Cancer Center, Columbia, TN., Sehovic M; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Reljic T; Maur y Regional Cancer Center, Columbia, TN., Djulbegovic B; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Maur y Regional Cancer Center, Columbia, TN., Lancet JE; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Malignant Hematology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Publikováno v: Haematologica [Haematologica] 2020 Jan 31; Vol. 105 (2), pp. 398-406. Date of Electronic Publication: 2020 Jan 31 (Print Publication: 2020).